Cryptotanshinone protects primary rat cortical neurons from glutamate-induced neurotoxicity via the activation of the phosphatidylinositol 3-kinase/Akt signaling pathway

被引:45
作者
Zhang, Fangyan [1 ]
Zheng, Wenhua [1 ]
Pi, Rongbiao [1 ]
Mei, Zhengrong [1 ]
Bao, Yingxia [1 ]
Gao, Jie [1 ]
Tang, Wenjie [1 ]
Chen, Shaorui [1 ]
Liu, Peiqing [1 ]
机构
[1] Sun Yat Sen Univ, Sch Pharmaceut Sci, Lab Pharmacol & Toxicol, Guangzhou 510080, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
Cryptotanshinone; Glutamate; Neuroprotection; PI3K; Akt; SALVIA-MILTIORRHIZA; OXIDATIVE STRESS; TANSHINONE-IIA; APOPTOSIS; INHIBITION; CELLS; NEUROPROTECTION; MECHANISMS; PI3-KINASE; PKB/AKT;
D O I
10.1007/s00221-008-1600-9
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Excitotoxicity contributes to neuronal death and is involved in the pathogenesis of neurodegenerative disorders such as Alzheimer's disease (AD). In the present study, cryptotanshinone, an active ingredient from a Chinese plant, Salvia miltiorrhiza, was investigated to assess its neuroprotective effects against glutamate-induced toxicity in primary culture of rat cortical neurons. Cryptotanshinone reversed glutamate-induced neuronal toxicity, which was characterized by decreased cell viability, increased lactate dehydrogenase release, neuronal DNA condensation, and the alteration of the expression of Bcl-2 family proteins. The neuroprotective effects of cryptotanshinone could be blocked by LY294002 and wortmannin, two inhibitors of PI3K. The importance of the PI3K pathway was further confirmed by the activation of Akt and anti-apoptotic Bcl-2 by cryptotanshinone in a PI3K-dependent manner. These results suggest that cryptotanshinone protects primary cortical neurons from glutamate-induced neurotoxicity through the activation of PI3K/Akt pathway. Such neuroprotective effects may be of interest in AD and other neurodegenerative diseases.
引用
收藏
页码:109 / 118
页数:10
相关论文
共 47 条
  • [1] Preclinical and clinical examinations of Salvia miltiorrhiza and its tanshinones in ischemic conditions
    Adams J.D.
    Wang R.
    Yang J.
    Lien E.J.
    [J]. Chinese Medicine, 1 (1)
  • [2] Neuroprotection by BDNF against glutamate-induced apoptotic cell death is mediated by ERK and PI3-kinase pathways
    Almeida, RD
    Manadas, BJ
    Melo, CV
    Gomes, JR
    Mendes, CS
    Graos, MM
    Carvalho, RF
    Carvalho, AP
    Duarte, CB
    [J]. CELL DEATH AND DIFFERENTIATION, 2005, 12 (10) : 1329 - 1343
  • [3] Dehydroepiandrosterone (DHEA) protects hippocampal cells from oxidative stress-induced damage
    Bastianetto, S
    Ramassamy, C
    Poirier, J
    Quirion, R
    [J]. MOLECULAR BRAIN RESEARCH, 1999, 66 (1-2): : 35 - 41
  • [4] Regulation of apoptosis by Bcl-2 family proteins
    Burlacu, A
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2003, 7 (03) : 249 - 257
  • [5] Activation of the PI3-K/AKT pathway and implications for radioresistance mechanisms in head and neck cancer
    Bussink, Johan
    van der Kogel, Albert J.
    Kaanders, Johannes H. A. M.
    [J]. LANCET ONCOLOGY, 2008, 9 (03) : 288 - 296
  • [6] Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons
    Chalecka-Franaszek, E
    Chuang, DM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (15) : 8745 - 8750
  • [7] GLUTAMATE NEUROTOXICITY AND DISEASES OF THE NERVOUS-SYSTEM
    CHOI, DW
    [J]. NEURON, 1988, 1 (08) : 623 - 634
  • [8] OXIDATIVE STRESS, GLUTAMATE, AND NEURODEGENERATIVE DISORDERS
    COYLE, JT
    PUTTFARCKEN, P
    [J]. SCIENCE, 1993, 262 (5134) : 689 - 695
  • [9] Implantation of BM mesenchymal stem cells into injured spinal cord elicits de novo neurogenesis and functional recovery:: evidence from a study in rhesus monkeys
    Deng, Y-B
    Liu, X-G
    Liu, Z-G
    Liu, X-L
    Liu, Y.
    Zhou, G-Q
    [J]. CYTOTHERAPY, 2006, 8 (03) : 210 - 214
  • [10] Neuroprotection by stem cell factor in rat cortical neurons involves AKT and NFκB
    Dhandapani, KM
    Wade, FM
    Wakade, C
    Mahesh, VB
    Brann, DW
    [J]. JOURNAL OF NEUROCHEMISTRY, 2005, 95 (01) : 9 - 19